Although mostly associated with acute inflammation and bacterial infection, IL-1β, IL-6 and TNF signaling pathways in the liver also play a significant role in disorders involving chronic inflammation such as obesity, insulin resistance, non-alcoholic steatohepatitis (NASH), viral hepatitis and fibrosis5–7. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatohepatitis.